ArticleCureus2026
Evaluation of Breast Lesions Using Multiparametric 3-Tesla Magnetic Resonance Imaging: A Cross-Sectional Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Breast cancer is the most common malignancy affecting women globally. Early and accurate characterization of breast lesions is essential for the accurate diagnosis of breast carcinoma, reducing unnecessary biopsies and improving overall survival. Multiparametric magnetic resonance imaging (MRI) at 3 Tesla (3T), incorporating dynamic contrast-enhanced MRI (DCE-MRI), diffusion-weighted imaging (DWI), and proton MR spectroscopy (MRS), has emerged as a promising diagnostic modality for breast lesion characterization. Objective This study aimed to evaluate the diagnostic accuracy of multiparametric 3T MRI in differentiating benign and malignant breast lesions using the Breast Imaging Reporting and Data System (BI-RADS) classification. Methods This hospital-based cross-sectional study was conducted in the Department of Radiodiagnosis in collaboration with the Department of General Surgery at the Regional Institute of Medical Sciences, Imphal, India, from January 2021 to October 2022. A total of 62 female patients aged above 18 years presenting with breast lesions were included. All patients had previously undergone ultrasonography examination for palpable breast lesions, either within the Department of Radiodiagnosis or at outside centers. Patients demonstrating positive or suspicious findings on ultrasonography were subsequently referred for multiparametric MRI of the breast. Ultrasonography findings were obtained from available reports; however, no statistical comparison between ultrasound and MRI findings was performed, as this was beyond the scope of the study. MRI findings were categorized according to BI-RADS criteria as per the American College of Radiology guidelines. Histopathological evaluation served as the reference standard. Diagnostic performance parameters were calculated. Statistical analysis was performed using IBM SPSS Statistics for Windows, Version 21.0 (IBM Corp., Armonk, New York, United States). Results Among 62 participants, the mean age of the participants was 51.1±10.2 years (range: 30-80 years). The most common presenting complaint was a breast lump, 62 (100%), followed by axillary swelling, 56 (90%). On MRI, most lesions demonstrated heterogeneous enhancement, 39 (62.7%), and irregular margins, 34 (55.2%). Type III kinetic curve (washout pattern) was the most frequent, 56 (89.5%). Diffusion restriction was consistently observed in malignant lesions. Increased choline peaks were observed in lesions where MR spectroscopy was performed. Histopathological evaluation revealed 57 malignant and five benign lesions. The diagnostic performance of multiparametric MRI using the BI-RADS scoring system demonstrated a sensitivity of 93%, a specificity of 60%, a positive predictive value (PPV) of 96.4%, and a negative predictive value (NPV) of 42.9%. A statistically significant association was observed between MRI findings and histopathological diagnosis (Fisher's exact test; p=0.008). The area under the receiver operating characteristic (ROC) curve was 0.968. Conclusion Multiparametric 3T MRI is a highly sensitive imaging modality for the characterization of breast lesions, with moderate specificity. Its use improves diagnostic accuracy and demonstrates a strong correlation with histopathological findings in patients with suspicious breast lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.